ABEONA THERAPEUTICS INC(NASDAQ:ABEO) stock News

ABEO Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: The Motley Fool

Abeona Posts Q2 Profit on Asset Sale

13 days ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates

13 days ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates

26 days ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

26 days ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: AscellaHealth, LLC

AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients

a month ago - By: Abeona Therapeutics Inc.

ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area

a month ago - By: Abeona Therapeutics Inc.

ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area

a month ago - By: Bio-Techne Corporation - Mentions: TECH

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa

2 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference

3 months ago - By: Benzinga - Mentions: PDD HMY HTHT PRTA ...

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

3 months ago - By: Benzinga - Mentions: IXHL HOLO DGLY IMNN ...

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates

3 months ago - By: Abeona Therapeutics Inc.

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

3 months ago - By: Abeona Therapeutics Inc.

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder

3 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder

4 months ago - By: Yahoo Finance - Mentions: DHI CMG

Abeona secures cash runway with $155m priority review voucher sale

4 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million

4 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million

4 months ago - By: Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Abeona Therapeutics Inc.

ABEONA THERAPEUTICS INC (ABEO) Stock News

ABEO Latest News, Press Relases and Analysis